Candidate biomarkers for the detection of coronary plaque destabilization and rupture

Anand Prasad, Sotirios Tsimikas

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Identification of high-risk patients presenting with chest pain remains challenging. The use of a single biomarker or a panel of biomarkers to detect occult plaque destabilization or rupture without frank infarction would allow for appropriate triage of such patients. Current data suggest that plaque vulnerability is determined by the relationship between forces that increase the size of the lipid core and destabilize the overlying thin fibrous cap. A variety of interrelated pathways are imputed to play important roles in this process of plaque evolution, destabilization, and rupture. These mechanisms include increased systemic and local inflammation, increased oxidative stress, matrix metalloproteinase modulation, and hemodynamic variables related to altered shear stress. Select candidate biomarkers that either reflect or influence these underlying processes and may ultimately have clinical application are highlighted in this review, which focuses on emerging biomarkers to define and predict the risks associated with the complex nature of vulnerable plaque biology.

Original languageEnglish (US)
Pages (from-to)309-317
Number of pages9
JournalCurrent Atherosclerosis Reports
Volume10
Issue number4
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

Rupture
Biomarkers
Triage
Matrix Metalloproteinases
Chest Pain
Infarction
Oxidative Stress
Hemodynamics
Inflammation
Lipids

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Candidate biomarkers for the detection of coronary plaque destabilization and rupture. / Prasad, Anand; Tsimikas, Sotirios.

In: Current Atherosclerosis Reports, Vol. 10, No. 4, 01.12.2008, p. 309-317.

Research output: Contribution to journalReview article

@article{f6277fc6284a4dbbbbabfa3bdc7d912e,
title = "Candidate biomarkers for the detection of coronary plaque destabilization and rupture",
abstract = "Identification of high-risk patients presenting with chest pain remains challenging. The use of a single biomarker or a panel of biomarkers to detect occult plaque destabilization or rupture without frank infarction would allow for appropriate triage of such patients. Current data suggest that plaque vulnerability is determined by the relationship between forces that increase the size of the lipid core and destabilize the overlying thin fibrous cap. A variety of interrelated pathways are imputed to play important roles in this process of plaque evolution, destabilization, and rupture. These mechanisms include increased systemic and local inflammation, increased oxidative stress, matrix metalloproteinase modulation, and hemodynamic variables related to altered shear stress. Select candidate biomarkers that either reflect or influence these underlying processes and may ultimately have clinical application are highlighted in this review, which focuses on emerging biomarkers to define and predict the risks associated with the complex nature of vulnerable plaque biology.",
author = "Anand Prasad and Sotirios Tsimikas",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/s11883-008-0048-5",
language = "English (US)",
volume = "10",
pages = "309--317",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Candidate biomarkers for the detection of coronary plaque destabilization and rupture

AU - Prasad, Anand

AU - Tsimikas, Sotirios

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Identification of high-risk patients presenting with chest pain remains challenging. The use of a single biomarker or a panel of biomarkers to detect occult plaque destabilization or rupture without frank infarction would allow for appropriate triage of such patients. Current data suggest that plaque vulnerability is determined by the relationship between forces that increase the size of the lipid core and destabilize the overlying thin fibrous cap. A variety of interrelated pathways are imputed to play important roles in this process of plaque evolution, destabilization, and rupture. These mechanisms include increased systemic and local inflammation, increased oxidative stress, matrix metalloproteinase modulation, and hemodynamic variables related to altered shear stress. Select candidate biomarkers that either reflect or influence these underlying processes and may ultimately have clinical application are highlighted in this review, which focuses on emerging biomarkers to define and predict the risks associated with the complex nature of vulnerable plaque biology.

AB - Identification of high-risk patients presenting with chest pain remains challenging. The use of a single biomarker or a panel of biomarkers to detect occult plaque destabilization or rupture without frank infarction would allow for appropriate triage of such patients. Current data suggest that plaque vulnerability is determined by the relationship between forces that increase the size of the lipid core and destabilize the overlying thin fibrous cap. A variety of interrelated pathways are imputed to play important roles in this process of plaque evolution, destabilization, and rupture. These mechanisms include increased systemic and local inflammation, increased oxidative stress, matrix metalloproteinase modulation, and hemodynamic variables related to altered shear stress. Select candidate biomarkers that either reflect or influence these underlying processes and may ultimately have clinical application are highlighted in this review, which focuses on emerging biomarkers to define and predict the risks associated with the complex nature of vulnerable plaque biology.

UR - http://www.scopus.com/inward/record.url?scp=58649109541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58649109541&partnerID=8YFLogxK

U2 - 10.1007/s11883-008-0048-5

DO - 10.1007/s11883-008-0048-5

M3 - Review article

C2 - 18618976

AN - SCOPUS:58649109541

VL - 10

SP - 309

EP - 317

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 4

ER -